Healmusz Wart Corn Remover

Description

The drug is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the removal of warts and corns.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be washed thoroughly with warm water. Soaking the wart in warm water for 5 minutes is optional but may enhance the effectiveness of the treatment. After cleansing, the area must be dried thoroughly to ensure proper adhesion of the medicated plaster.

If necessary, the plaster can be cut to fit the size of the wart. The medicated plaster should then be applied directly to the wart. Treatment may be repeated every 48 hours as needed, for a maximum duration of 12 weeks.

Contraindications

Use is contraindicated on irritated, infected, or reddened skin due to the potential for exacerbating the condition. Application is also contraindicated on genital warts or warts located on the face, as well as on moles, birthmarks, or warts with hair growing from them, to avoid adverse reactions. Additionally, the product should not be applied to mucous membranes, as this may lead to irritation or other complications.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid ingestion of the product. In the event of accidental swallowing, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Patients with diabetes or those experiencing poor blood circulation are advised to consult a healthcare provider prior to use. This precaution is essential to ensure safe application and to mitigate any potential complications associated with these conditions.

Should any discomfort persist or worsen during the use of this product, patients must discontinue use immediately and seek guidance from their healthcare provider. Monitoring for adverse reactions is crucial to ensure patient safety and effective management of any side effects.

Side Effects

For external use only. Patients should stop use and consult a doctor if discomfort persists or worsens. Additionally, individuals with diabetes or poor blood circulation are advised to seek medical advice before using this product.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Healmusz Wart Corn Remover (salicylic acid 40% wart corn remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of HEALMUSZ WART CORN REMOVER during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in women who are pregnant or may become pregnant, as the potential risks to fetal outcomes are not established. It is advisable to weigh the benefits against any unknown risks when making treatment decisions for this population.

Lactation

No information related to nursing mothers or lactation is provided in the drug insert for HEALMUSZ WART CORN REMOVER. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk are unknown. Healthcare professionals should exercise caution when considering the use of this product in lactating mothers.

Renal Impairment

Dosage adjustments may be necessary for patients with reduced renal function. It is important to monitor renal function tests regularly in patients with known kidney problems. A reduced dose should be considered in patients with a creatinine clearance of less than 30 mL/min.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific details regarding overdosage for this medication (SPL code 34088-5), it is essential for healthcare professionals to remain vigilant and consider general principles of management in cases of suspected overdosage.

Recommended Actions In the event of an overdosage, immediate medical attention should be sought. Healthcare providers are advised to assess the patient's clinical status and initiate supportive care as necessary. Monitoring vital signs and providing symptomatic treatment may be required based on the patient's condition.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should be aware that symptoms can vary widely depending on the substance involved. Common signs of overdosage may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

Management Procedures Management of overdosage should be tailored to the individual patient and may include decontamination procedures such as activated charcoal, if appropriate and within the timeframe of ingestion. In severe cases, advanced interventions may be necessary, including airway management and intravenous fluids. Consultation with a poison control center or a medical toxicologist is recommended for guidance on specific treatment protocols.

In summary, while specific overdosage information is not provided, healthcare professionals should be prepared to act swiftly and effectively in the event of an overdose, utilizing general principles of emergency care and supportive management.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, patients should be instructed to avoid using the product on mucous membranes.

Healthcare providers should counsel patients to discontinue use and consult a doctor if discomfort persists or worsens. Patients must also be cautioned to avoid contact with the eyes or face; in the event that the product comes into contact with the eyes, they should rinse thoroughly with water.

Furthermore, it is essential to advise patients to consult a doctor if they have diabetes or poor blood circulation before using the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 59°F to 86°F (15°C to 30°C) to maintain its efficacy and integrity. Proper storage conditions should be observed to ensure optimal performance.

Additional Clinical Information

The medicated plaster is administered topically, with application recommended every 48 hours as needed, for a maximum duration of 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Healmusz Wart Corn Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)